Stocks › BNS
Bank Nova Scotia Halifax Pfd 3 (BNS) stock analysis
WEAK SELL 12% confidence · analysed Oct 13, 2026
On Oct 13, 2026, our model rated Bank Nova Scotia Halifax Pfd 3 (BNS) WEAK SELL with 12% confidence at a price of $88.80. That means the signals lean negative, but they are mixed, so conviction is low.
Technical picture
The 14-day RSI is 32. Momentum is soft: below the neutral 50 line, but not yet oversold.
MACD is below its signal line, so short-term momentum is pointing down.
The price has slipped below its 50-day moving average but is still above the 200-day: a pullback inside a longer-term uptrend.
Volume is only 0.2x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure shows a bullish break of structure (BOS): price broke a recent swing high in the direction of the trend, which usually signals trend continuation.
The most recent swing high is $76.00 and the swing low is $65.10; traders often treat these as resistance and support.
Price is sitting in a bullish order block, a zone where large buyers stepped in before.
Fundamentals
The PEG ratio is 1.00, which looks reasonably priced for its growth.
The company reports a profit margin of 28.4% and revenue growth of +11.7%.
In its latest quarter it earned $2.28 per share, which beat the $2.10 analysts expected, with revenue +10.5% year over year.
Wall Street's average rating is 2.6 on a 1 (strong buy) to 5 (sell) scale, roughly a "hold", with an average price target of $89.70.
The next earnings report is expected around Dec 2, 2026; prices often move sharply around earnings.
Trade plan from the model
The model's short / bearish plan uses an entry near $88.83, a target of $87.07 (-2.0%) and a stop-loss at $91.64 (+3.2%).
That is a reward-to-risk ratio of about 0.6 to 1: the potential loss is bigger than the gain, a weak setup.
The plan has a time limit: reassess by Oct 23, 2026 whatever the price does.
Research notes
Scotiabank’s bull case has strengthened: Q3 adjusted EPS rose 21% year over year to C$2.28, adjusted ROE reached 14.2%, revenue increased 11.1%, and CET1 capital remained strong at 13.1%. The bear case is that shares have recently pulled back roughly 3% over the past week and month amid higher bond yields, possible further interest-rate increases, and ongoing concerns about credit quality and efficiency. The major new catalyst is the October expansion of Scotiabank’s normal-course issuer bid from 15 million to 40 million shares, supporting per-share growth and capital returns. This latest information broadly agrees with the prior neutral view: fundamentals and buybacks have improved, but recent price weakness and macro risks have not yet produced decisive upside confirmation.
The model's one-paragraph read
Leans SELL / avoid — composite score -0.12 (WEAK SELL). Technicals: RSI 32.37, MACD bearish, price below SMA50. Fundamentals: PEG 1.00, margin 28.4%, revenue growth 11.7%. Financial results: YoY revenue +10.5%, last EPS surprise +8.6%, next earnings 2026-12-02. Smart Money Concepts: BOS bullish (trend continuation), price retesting a bullish order block, price retesting a bearish order block, sitting inside an unfilled bearish fair value gap. FinGPT news read: neutral. Memory: 9 prior look(s); 14% of directional calls matched later price. Internet research: Scotiabank’s bull case has strengthened: Q3 adjusted EPS rose 21% year over year to C$2.28, adjusted ROE reached 14.2%, revenue increased 11.1%, and CET1 capital remained strong at 13.1%. The bear case is that shares have recently pulled back roughly 3% over the past week and month amid higher bond yields, possible further interest-rate increases, and ongoing concerns about credit quality and efficiency. The major new catalyst is the October expansion of Scotiabank’s normal-course issuer bid from 15 million to 40 million shares, supporting per-share growth and capital returns. This latest information broadly agrees with the prior neutral view: fundamentals and buybacks have improved, but recent price weakness and macro risks have not yet produced decisive upside confirmation. Suggested levels: entry $88.83, target $87.07, stop-loss $91.64, exit by 2026-10-23 (10-calendar-day max hold (time-stop; reassess by this date regardless of P&L)).
Past ratings for BNS
Of the last 5 directional calls on BNS, 1 pointed the right way by the most recent analysis (20%). Past calls do not guarantee future results.
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Oct 13, 2026 | WEAK SELL | 12% | $88.80 | — | |
| Oct 12, 2026 | SKIP | 5% | $88.45 | +0.4% | |
| Oct 9, 2026 | WEAK BUY | 18% | $87.59 | +1.4% | ✔ right direction |
| Oct 5, 2026 | SKIP | 9% | $90.70 | -2.1% | |
| Oct 1, 2026 | SKIP | 2% | $89.12 | -0.4% | |
| Sep 30, 2026 | SKIP | 8% | $92.47 | -4.0% | |
| Sep 29, 2026 | WEAK BUY | 28% | $92.75 | -4.3% | ✘ wrong direction |
| Sep 28, 2026 | WEAK BUY | 24% | $92.91 | -4.4% | ✘ wrong direction |
| Sep 24, 2026 | WEAK BUY | 29% | $92.25 | -3.7% | ✘ wrong direction |
| Sep 8, 2026 | BUY | 35% | $93.82 | -5.4% | ✘ wrong direction |
"Move since" compares each call's price with the latest analysed price.
Other Financial Services stocks we cover
BPRE · BRW · BSTZ · CB · CHI · CHW · CHY · CION · COIN · COLB · CRF · DBL
Frequently asked questions
Is BNS a buy right now?
As of Oct 13, 2026, our automated model rates Bank Nova Scotia Halifax Pfd 3 (BNS) WEAK SELL with 12% confidence: the signals lean negative, but they are mixed, so conviction is low. This is a model output for education, not personal investment advice.
What is the price target for BNS?
The model's most recent plan targets $87.07 with a stop-loss at $91.64, from an entry near $88.83.
When does Bank Nova Scotia Halifax Pfd 3 report earnings next?
The next earnings report is expected around Dec 2, 2026.
What does a WEAK SELL rating mean?
A WEAK SELL rating means the signals lean negative, but they are mixed, so conviction is low.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.